System Secures $20M Funding to Dominate $163B Peptide Market

San Francisco-based System aims to emerge as the leading player in the $163B peptide market with $20M funding, as the FDA's expanded access propels peptides into the mainstream. The investment seeks to enhance accessibility to peptide treatments, historically costly and inaccessible.